Literature DB >> 11602669

Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.

X Y Chu1, G P Sánchez-Castaño, K Higaki, D M Oh, C P Hsu, G L Amidon.   

Abstract

The proton-coupled oligopeptide transporter (PEPT1) has been shown to mediate mucosal cell transport of di- and tripeptide, and some peptidomimetic drugs. In this study, we determined the correlation between PEPT1 protein expression and the permeability of cephalexin, a substrate of PEPT1, in human PEPT1 (hPEPT1)-overexpressed Caco-2 cells (Caco-2/hPEPT1 cells) and rat jejunum. Caco-2/hPEPT1 cells with various levels of hPEPT1 expression were established by an adenoviral transfection system. The effective intestinal permeability (P(eff)) in rat jejunum was evaluated using a single pass in situ perfusion method. The level of PEPT1 in Caco-2/hPEPT1 cells and rat intestinal mucosal samples was quantitated by densitometry after immunoblotting and enhanced chemiluminescence detection. In Caco-2/hPEPT1 cells, an excellent correlation was observed between cephalexin uptake and hPEPT1 expression (R2 = 0.96, P < 0.005). This demonstrates that cephalexin uptake is directly proportional to hPEPT1 expression. In the rat perfusion study, the mean P(eff) +/- S.D. (n = 15) of cephalexin was 3.89 +/- 1.63 x 10(-5) cm/s. A very significant correlation between PEPT1 expression and cephalexin permeability with an R2 = 0.63 (P < 0.001) was observed. This indicates that the variation in PEPT1 expression is one of the major factors accounting for variable intestinal cephalexin absorption. To our knowledge, this is the most direct evidence that variation of PEPT1 expression is correlated with absorption permeability variation of peptide-like compounds in vitro and in vivo.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2001        PMID: 11602669

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs.

Authors:  Duxin Sun; Hans Lennernas; Lynda S Welage; Jeffery L Barnett; Christopher P Landowski; David Foster; David Fleisher; Kyung-Dall Lee; Gordon L Amidon
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

2.  Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor.

Authors:  Dana D Phan; Peter Chin-Hong; Emil T Lin; Pascale Anderle; Wolfgang Sadee; B Joseph Guglielmo
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

3.  Prediction of glycylsarcosine transport in Caco-2 cell lines expressing PEPT1 at different levels.

Authors:  Megumi Irie; Tomohiro Terada; Masahiro Tsuda; Toshiya Katsura; Ken-Ichi Inui
Journal:  Pflugers Arch       Date:  2005-11-10       Impact factor: 3.657

Review 4.  Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.

Authors:  Xianhua Cao; Seth T Gibbs; Lanyan Fang; Heather A Miller; Christopher P Landowski; Ho-Chul Shin; Hans Lennernas; Yanqiang Zhong; Gordon L Amidon; Lawrence X Yu; Duxin Sun
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

5.  Quantitative evaluation of PEPT1 contribution to oral absorption of cephalexin in rats.

Authors:  Takanori Hironaka; Shota Itokawa; Ken-ichi Ogawara; Kazutaka Higaki; Toshikiro Kimura
Journal:  Pharm Res       Date:  2008-09-11       Impact factor: 4.200

6.  Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.

Authors:  Caroline A Larregieu; Leslie Z Benet
Journal:  AAPS J       Date:  2013-01-24       Impact factor: 4.009

7.  PepT1 mRNA expression is induced by starvation and its level correlates with absorptive transport of cefadroxil longitudinally in the rat intestine.

Authors:  Kazumasa Naruhashi; Yoshimichi Sai; Ikumi Tamai; Nagao Suzuki; Akira Tsuji
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

8.  Abnormal expression of the peptide transporter PepT1 in the colon of massive bowel resection rat: a potential route for colonic mucosa damage by transport of fMLP.

Authors:  Bin Shi; Desheng Song; Hua Xue; Jinhai Li; Ning Li; Jieshou Li
Journal:  Dig Dis Sci       Date:  2006-09-29       Impact factor: 3.199

9.  Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine.

Authors:  Michael Pennick
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

10.  Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells.

Authors:  Yu-Yuan Chiu; Kazutaka Higaki; Brien L Neudeck; Jeffrey L Barnett; Lynda S Welage; Gordon L Amidon
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.